RHJA
PLRX icon

Rice Hall James & Associates’s Pliant Therapeutics PLRX Stock Holding History

Rice Hall James & Associates’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-147,705
Closed -$180K – 253
2025
Q4 		$180K Buy
147,705
+2,862
+2% +$4.3K 0.01% 243
2025
Q3 		$214K Sell
144,843
-16,405
-10% -$25K 0.01% 246
2025
Q2 		$187K Buy
161,248
+8,254
+5% +$11.7K 0.01% 247
2025
Q1 		$207K Sell
152,994
-7,528
-5% -$45.7K 0.01% 248
2024
Q4 		$2.11M Buy
160,522
+3,305
+2% +$45.1K 0.12% 171
2024
Q3 		$1.76M Buy
157,217
+29,583
+23% +$370K 0.1% 184
2024
Q2 		$1.37M Buy
+127,634
New +$1.65M 0.08% 192

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return